Insight into the Chinese ultrasound imaging diagnostic equipment market in the first quarter of 2025
This report aims to comprehensively analyze the scale, brand structure, regional differentiation performance, and other aspects of the domestic ultrasound imaging diagnostic equipment market in the first quarter of 2025, and gain insights into market trends.
01
After doubling the market size, it fell back, and domestic brands contributed more than 40%
In the first quarter of 2025, the market size of ultrasound imaging diagnostic equipment in China grew rapidly year-on-year, with a growth rate of nearly 90%. After doubling in the fourth quarter of 2024, the market size has slightly declined.
The localization rate of China’s ultrasound imaging diagnostic equipment market in the first quarter of 2025 was about 42%, an increase of 4.03 percentage points compared to the same period last year.
02
The overall market competition pattern is stable, and the market share of top brands has slightly increased
In the first quarter of 2025, the top five brands in China’s ultrasound imaging diagnostic equipment market remained unchanged in terms of market share, with Mindray Medical’s market share ranking rising one place to the top, with a year-on-year increase of 4.14 percentage points in market share. In addition, Philips and SonoScape’s medical market share has also significantly increased compared to the same period last year.
Among them, Philips has a higher market share and the most significant year-on-year increase in market share. In addition, SonoScape Medical and Samsung Medison’s market share has also increased compared to the same period last year. Compared to the overall market of ultrasound imaging diagnostic equipment in public hospitals, the brand market concentration (CR4) of county-level hospitals was relatively low.
03
Regional market procurement remains stable, with a higher localization rate in the western region
In the first quarter of 2025, there was a slight increase in the procurement of ultrasound imaging diagnostic equipment in the western region, while there was a slight decrease in the eastern and central regions.
From the perspective of brand market share, Mindray Medical, Philips, and GE Healthcare have relatively balanced performance in various regions across the country, while SonoScape Medical was more active in the western region.
04
The proportion of procurement in tertiary hospitals has further increased, with Mindray Medical having a relatively obvious advantage
In the first quarter of 2025, the procurement of ultrasound imaging diagnostic equipment in China still mainly focused on tertiary hospitals, with a significantly increased proportion of about 74%.
From the market pattern of ultrasound imaging diagnostic equipment in domestic tertiary and secondary hospitals, Mindray Medical had the highest market share in the procurement of tertiary hospitals, while Philips had the most advantage in the procurement of secondary hospitals.
Conlusion
Overall, in the first quarter of 2025, the market for ultrasound imaging diagnostic equipment in China was still mainly dominated by domestic leading companies Mindray, overseas companies Philips, and GE Healthcare. The market share of the three companies was comparable, and there was a significant gap between them and other brands. In addition to the three major giants, domestic medical brands Sono Scape and overseas brand Siemens also had relatively strong development trends, while other enterprises jointly occupied about 30% of the market share.
The technological innovation points of China’s ultrasound imaging equipment in 2024 mainly laid in the improvement of imaging methods, the enhancement of computational efficiency, and the portable design of probes, with few revolutionary technological breakthroughs. In early April this year, after the United States announced its “reciprocal tariff” policy towards China, the Chinese government retaliated strongly, resulting in a significant increase in the cost of products exported by domestic American companies to China. As the earliest and most comprehensive American domestic enterprise to localize in China, GE Healthcare has now produced the vast majority of ultrasound imaging equipment locally in China, greatly avoiding the potential impact of tariffs. However, the tariff policy has dealt a heavy blow to the global industrial chain, and the development of foreign brands in China may still be slightly affected. At the same time, the difficulty of domestic brands going abroad to the United States has increased, and exploring broader overseas markets will become an important path for performance growth.
China is encouraging China end uses for more domestic products in latest years. Thus, more and more overseas manufacturers are planning localization in China. BradyKnows localization team has extensive experiences in facility establishment, audit, supplier evaluation, manufacturing, registration, and marketing in China. Pls feel free to let us know any questions on China entry via info@bradyknowsmedical.com
Source：MDDI
Translated & edited： Bradyknown
